3 completed, 2 recruiting, 1 unknown. 6 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 3, Recruiting 2, Unknown 1 |
Follow Drug-resistant Tuberculosis: new trials by email Literature Review of Drug-resistant Tuberculosis trials Research Report on Drug-resistant Tuberculosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis Therapeutic Drug Monitoring for Linezolid - Rifampin-resistant Tuberculosis, Drug-resistant Tuberculosis | Not applicable | Recruiting | Albert Einstein College of Medicine | 280 | 2026-04-07 | 2026-05-04 |
| Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis Targeted next-generation sequencing - Drug-resistant Tuberculosis, HIV Coinfection | Not applicable | Recruiting | University of California, San Francisco | 2500 | 2024-08-01 | 2026-01-26 |
| Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial WGS DST strategy - Rifampicin Resistant Tuberculosis, Drug-resistant Tuberculosis | Not applicable | Unknown | Universiteit Antwerpen | 248 | 2021-09-21 | 2021-10-15 |
| Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes Keheala Mobile Health Platform and Behavioral Interventions, Social and Behavior Change Communication (SBCC), SMS Reminder - Tuberculosis, Adherence, Patient | Not applicable | Completed | Massachusetts Institute of Technology | 16146 | 2018-04-13 | 2022-01-21 |
| An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment Electronic DOT, In-person DOT - Tuberculosis, Drug-resistant Tuberculosis | Not applicable | Completed | Centers for Disease Control and Prevention | 216 | 2017-07-19 | 2026-07-02 |
| Rewards for Tuberculosis Contact Screening Contacts, Index - Tuberculosis, Drug-resistant Tuberculosis | Not applicable | Completed | Boston University | 301 | 2014-10-01 | 2021-01-08 |
Tuberculosis, Multidrug-Resistant (6) · Tuberculosis (3) · Medication Adherence (2) · Patient Compliance (2) · Directly Observed Therapy (1) · HIV Infections (1) · Tuberculosis, Pulmonary (1)
Actinomycetales Infections (6) · Bacterial Infections (6) · Bacterial Infections and Mycoses (6) · Gram-Positive Bacterial Infections (6) · Infections (6) · Mycobacterium Infections (6) · Tuberculosis (3) · Behavior (2) · Health Behavior (2) · Patient Acceptance of Health Care (2) · Treatment Adherence and Compliance (2) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · Immune System Diseases (1)
Behavior Therapy (1) · Linezolid (1) · Standard of Care (1)
Albert Einstein College of Medicine (1) · Boston University (1) · Centers for Disease Control and Prevention (1) · Massachusetts Institute of Technology (1) · Universiteit Antwerpen (1) · University of California, San Francisco (1)
South Africa (4) · Kenya (1) · United States (1)
Annelies Van Rie, PhD, MD (1) · Gary Maartens, MBChB (1) · Gavin Churchyard, PhD, MD (1) · James CM Brust, MD (1) · John Z Metcalfe, MD, PhD (1) · Joseph Burzynski, MD, MPH (1) · Rob M Warren, PhD (1) · Salome Charalambous, PhD (1) · Sydney Rosen (1)
PMID 35050357, PMID 36209235, PMID 37035970, PMID 42026006
R01AI153213 (1), R01AI184416 (1), U01AI100015 (1)